You-yong Tian

No.68, Changle Road
Nanjing, 210006, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Mid-long term efficacy of dihydroergotoxine mesylate in treatment of sialorrhea in Parkinson's disease.

Mid-long term efficacy of dihydroergotoxine mesylate in treatment of sialorrhea in Parkinson's disease.

Journal: Clinical neurology and neurosurgery

Published: July 14, 2025

Motor symptoms of Parkinson's disease are affected by temperature: A controlled pilot study.

Motor symptoms of Parkinson's disease are affected by temperature: A controlled pilot study.

Journal: Brain and behavior

Published: September 08, 2023

Drooling disrupts the brain functional connectivity network in Parkinson's disease.

Drooling disrupts the brain functional connectivity network in Parkinson's disease.

Journal: CNS neuroscience & therapeutics

Published: January 24, 2023

Dysregulation of Circulatory Levels of lncRNAs in Parkinson's Disease.

Dysregulation of Circulatory Levels of lncRNAs in Parkinson's Disease.

Journal: Molecular neurobiology

Published: May 01, 2022

Angiotensin-(1-7) reduces α-synuclein aggregation by enhancing autophagic activity in Parkinson's disease.

Angiotensin-(1-7) reduces α-synuclein aggregation by enhancing autophagic activity in Parkinson's disease.

Journal: Neural regeneration research

Published: September 24, 2021

Contralateral Posterior Putaminal 18F-Fluorodopa Uptake in Mild Stage Parkinson's Disease: A PET/CT Study.

Contralateral Posterior Putaminal 18F-Fluorodopa Uptake in Mild Stage Parkinson's Disease: A PET/CT Study.

Journal: Current neurovascular research

Published: September 15, 2021

Han Chinese family with early-onset Parkinson's disease carries novel compound heterozygous mutations in the PARK2 gene.

Han Chinese family with early-onset Parkinson's disease carries novel compound heterozygous mutations in the PARK2 gene.

Journal: Brain and behavior

Published: March 14, 2019

Dihydroergotoxine mesylate for the treatment of sialorrhea in Parkinson's disease.

Dihydroergotoxine mesylate for the treatment of sialorrhea in Parkinson's disease.

Journal: Parkinsonism & related disorders

Published: March 10, 2018

PM2.5 exposure aggravates oligomeric amyloid beta-induced neuronal injury and promotes NLRP3 inflammasome activation in an in vitro model of Alzheimer's disease.

PM2.5 exposure aggravates oligomeric amyloid beta-induced neuronal injury and promotes NLRP3 inflammasome activation in an in vitro model of Alzheimer's disease.

Journal: Journal of neuroinflammation

Published: January 16, 2018

Azilsartan ameliorates apoptosis of dopaminergic neurons and rescues characteristic parkinsonian behaviors in a rat model of Parkinson's disease.

Azilsartan ameliorates apoptosis of dopaminergic neurons and rescues characteristic parkinsonian behaviors in a rat model of Parkinson's disease.

Journal: Oncotarget

Published: January 02, 2017

Mitochondrial-dependent mechanisms are involved in angiotensin II-induced apoptosis in dopaminergic neurons.

Mitochondrial-dependent mechanisms are involved in angiotensin II-induced apoptosis in dopaminergic neurons.

Journal: Journal of the renin-angiotensin-aldosterone system : JRAAS

Published: June 10, 2016

Independent Correlation of Serum Homocysteine with Cerebral Microbleeds in Patients with Acute Ischemic Stroke due to Large-Artery Atherosclerosis.

Independent Correlation of Serum Homocysteine with Cerebral Microbleeds in Patients with Acute Ischemic Stroke due to Large-Artery Atherosclerosis.

Journal: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association

Published: May 06, 2016

Showing 1-12 of 21

Last Updated: 09/26/2026